Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

A Study to Investigate Interchangeability of ABP 654 for the Treatment of Participants With Moderate to Severe Plaque Psoriasis

ClinicalTrials.gov ID: NCT04761627

Public ClinicalTrials.gov record NCT04761627. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 26, 2026, 12:10 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multicenter, Randomized, Double-blinded Study Evaluating the Pharmacokinetics, Efficacy and Safety of Multiple Switches Between Ustekinumab and ABP 654 Compared With Continued Use of Ustekinumab in Subjects With Moderate to Severe Plaque Psoriasis

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of the study is to evaluate pharmacokinetic similarity, efficacy, safety and immunogenicity of multiple switches between ustekinumab and ABP 654 compared with continued use of ustekinumab in participants with moderate to severe plaque psoriasis.

Study identification

NCT ID
NCT04761627
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Amgen
Industry
Enrollment
494 participants

Conditions and interventions

Conditions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years to 75 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 24, 2021 (Actual)
Primary completion
Feb 28, 2023 (Actual)
Completion
Feb 28, 2023 (Actual)
Last update posted
Jan 11, 2024

2021 – 2023

United States locations

U.S. sites
31
U.S. states
18
U.S. cities
31
Facility City State ZIP Site status
Burke Pharmaceutical Research Hot Springs Arkansas 71913 —
Zenith Research Inc. Beverly Hills California 90212 —
Center for Dermatology Clinical Research, Inc. Fremont California 94538 —
Quest Dermatology Research Northridge California 91324-4669 —
Southern California Dermatology, Inc Santa Ana California 92701 —
Encore Research Group-Jacksonville Center for Clinical Resea Jacksonville Florida 32216 —
Altus Research, Inc. Lake Worth Florida 33461 —
International Dermatology Research, Inc. Miami Florida 33144 —
Leavitt Medical Associates of Florida d/b/a Ameriderm Research Ormond Beach Florida 32174 —
Riverchase Dermatology and Cosmetic Surgery Pembroke Pines Florida 33028-1013 —
Olympian Clinical Research Tampa Florida 33614 —
Hamilton Research, LLC Alpharetta Georgia 30022 —
Advanced Medical Research PC Sandy Springs Georgia 30328 —
Dundee Dermatology West Dundee Illinois 60118 —
DS Research Clarksville Indiana 47129 —
Integrated Clinical Trial Services Inc. West Des Moines Iowa 50265 —
Kansas Medical Clinic, PA Topeka Kansas 66614 —
Clinical Pharmacology Study Group Worcester Massachusetts 01605 —
Hamzavi Dermatology Fort Gratiot Michigan 48059 —
Minnesota Clinical Study Center New Brighton Minnesota 55112 —
MediSearch Clinical Trials Saint Joseph Missouri 64506 —
Skin Specialists PC Omaha Nebraska 68144 —
ActivMed Practices & Research, LLC. Portsmouth New Hampshire 03801 —
Psoriasis Treatment Center of Central New Jersey East Windsor New Jersey 08520 —
The Dermatology Group, PC Verona New Jersey 07044 —
Wilmington Dermatology Center Wilmington North Carolina 28405 —
Oregon Medical Research Center Portland Oregon 97223 —
Austin Institute for Clinical Research, Inc. Dripping Springs Texas 78620 —
Austin Institute for Clinical Research, Inc - Dermatology Pflugerville Texas 78660 —
Progressive Clinical Research [Texas] San Antonio Texas 78213 —
Center for Clinical Studies, LTD., LLP Webster Texas 77598 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 57 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04761627, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 11, 2024 · Synced Oct 26, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT04761627 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →